Lloyd J K, West R J
Postgrad Med J. 1978 Mar;54(629):190-6. doi: 10.1136/pgmj.54.629.190.
Of the primary hyperlipidaemias, familial hypercholesterolaemia (hyerbetalipoproteinaemia, type II) is always expressed in childhood and carries a high risk for the early development of coronary heart disease. The diagnosis can be established with a high degree of certainty by estimating the serum cholesterol concentration in selected children in whom the genetic risk is known to be great, e.g. if a parent or other first-degree relative is known to have the disease, or if a parent has had an attack of ischaemic heart disease at a young age. Screening of the general population in order to detect this disorder is not advocated. Treatment by either diet or drugs will lower serum cholesterol but long-term compliance is poor and the effect of treatment on the atherosclerotic process has not been evaluated. Follow-up studies must be maintained. Familial hypertriglyceridaemic states are rarely fully expressed during childhood, and screening for them at this age is not practicable. Control of co-existent obesity and dietary treatment are usually successful in lowering serum lipids but long-term results have not yet been evaluated. In a childhood population, single estimations of serum cholesterol or triglyceride should be interpreted with caution. Percentile rank correlations for serum cholesterol are of the order of 0·61 and for triglyceride of 0·31. Prediction of adult values cannot therefore be assured in childhood and the place of hyperlipidaemia in the childhood population as a risk factor for coronary heart disease in adult life is not established. Thus population screening of serum lipids in children cannot be justified. Evidence that a change in the diet of children which would be expected to lower serum lipids will also delay the development of atherosclerosis in general and coronary heart disease in particular is lacking. Nevertheless the dietary changes which have been recommended for adults can safely be followed by children, and changes in eating habits are perhaps more likely to succeed if promoted on a family basis rather than for individual sections of the population.
在原发性高脂血症中,家族性高胆固醇血症(高β脂蛋白血症,II型)在儿童期总会显现,且患冠心病早期发展的风险很高。对于已知遗传风险很大的特定儿童,例如父母或其他一级亲属患有该病,或者父母在年轻时曾患缺血性心脏病,通过估算血清胆固醇浓度可高度确定地做出诊断。不提倡对普通人群进行筛查以检测这种疾病。通过饮食或药物治疗可降低血清胆固醇,但长期依从性较差,且治疗对动脉粥样硬化进程的影响尚未评估。必须持续进行随访研究。家族性高甘油三酯血症状态在儿童期很少完全显现,在此年龄对其进行筛查不切实可行。控制并存的肥胖和饮食治疗通常能成功降低血脂,但长期效果尚未评估。在儿童群体中,单次血清胆固醇或甘油三酯测定结果的解读应谨慎。血清胆固醇的百分位数等级相关性约为0.61,甘油三酯的约为0.31。因此,儿童期无法确定地预测成人血脂值,且高脂血症在儿童群体中作为成人期冠心病风险因素的地位尚未确立。所以,对儿童进行血脂普查并无道理。缺乏证据表明预期能降低血脂的儿童饮食改变也会总体上延缓动脉粥样硬化的发展,特别是冠心病的发展。然而,已推荐给成年人的饮食改变儿童可以安全地遵循,而且如果以家庭为基础推广而非针对特定人群,饮食习惯的改变可能更易成功。